The effect of Vortioxetine on the NLRP3 pathway and microglial activity in the prefrontal cortex in an experimental model of depression

References

• Smith KE, Pollak SD. Early life stress and development: potential mechanisms for adverse outcomes. J Neurodev Disord. 2020;12(1):34. doi: 10.1186/s11689-020-09337-y.
   PubMed Web of Science ®Google Scholar
• LeMoult J, Humphreys KL, Tracy A, et al. Meta-analysis: exposure to early life stress and risk for depression in childhood and adolescence. J Am Acad Child Adolesc Psychiatry. 2020;59(7):842–855. doi: 10.1016/j.jaac.2019.10.011.
   PubMed Web of Science ®Google Scholar
• Danese A, S JL. Psychoneuroimmunology of early-life stress: the hidden wounds of childhood trauma? Neuropsychopharmacology. 2017;42(1):99–114. doi: 10.1038/npp.2016.198.
   PubMed Web of Science ®Google Scholar
• Prinz M, Priller J. Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease. Nat Rev Neurosci. 2014;15(5):300–312. doi: 10.1038/nrn3722.
   PubMed Web of Science ®Google Scholar
• Sanchez C, Asin KE, Artigas F. Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data. Pharmacol Ther. 2015;145:43–57. doi: 10.1016/j.pharmthera.2014.07.001.
   PubMed Web of Science ®Google Scholar
• Bennabi D, Haffen E, Van Waes V. Vortioxetine for cognitive enhancement in major depression: from animal models to clinical research. Front Psychiatry. 2019;10:771. doi: 10.3389/fpsyt.2019.00771.
   PubMed Web of Science ®Google Scholar
• Taskiran M, Unal G. Vortioxetine suppresses epileptiform activity and cognition deficits in a chronic PTZ-induced kindling rat model. Epileptic Disord. 2021 Dec 1;23(6):893–900. doi: 10.1684/epd.2021.1344.
   PubMed Web of Science ®Google Scholar
• Tomaz VS, Chaves Filho AJM, Cordeiro RC, et al. Antidepressants of different classes cause distinct behavioral and brain pro- and anti-inflammatory changes in mice submitted to an inflammatory model of depression. J Affect Disord. 2020;268:188–200. doi: 10.1016/j.jad.2020.03.022.
   PubMed Web of Science ®Google Scholar
• Alboni S, Benatti C, Colliva C, et al. Vortioxetine prevents lipopolysaccharide-induced memory impairment without inhibiting the initial inflammatory Cascade. Front Pharmacol. 2020;11:603979. doi: 10.3389/fphar.2020.603979.
   PubMed Web of Science ®Google Scholar
• Thomas AJ, Davis S, Morris C, et al. Increase in interleukin-1beta in late-life depression. Am J Psychiatry. 2005;162(1):175–177. doi: 10.1176/appi.ajp.162.1.175.
   PubMed Web of Science ®Google Scholar
• Kaufmann FN, Costa AP, Ghisleni G, et al. NLRP3 inflammasome-driven pathways in depression: clinical and preclinical findings. Brain Behav Immun. 2017;64:367–383. doi: 10.1016/j.bbi.2017.03.002.
   PubMed Web of Science ®Google Scholar
• Özdamar Ünal G, Hekimler Öztürk K, Erkılınç G, et al. Maternal prenatal stress and depression-like behavior associated with hippocampal and cortical neuroinflammation in the offspring: an experimental study. Intl J of Devlp Neuroscience. 2022;82(3):231–242. doi: 10.1002/jdn.10176.
   PubMed Web of Science ®Google Scholar
• Haapakoski R, Mathieu J, Ebmeier KP, et al. Cumulative meta-analysis of interleukins 6 and 1beta, tumour necrosis factor alpha and C-reactive protein in patients with major depressive disorder. Brain Behav Immun. 2015;49:206–215. doi: 10.1016/j.bbi.2015.06.001.
   PubMed Web of Science ®Google Scholar
• Liu FR, Yang LY, Zheng HF, et al. Plasma levels of Interleukin 18 but not amyloid-beta or Tau are elevated in female depressive patients. Compr Psychiatry. 2020;97:152159. doi: 10.1016/j.comppsych.2020.152159.
   PubMed Web of Science ®Google Scholar
• Ribeiro DE, Roncalho AL, Glaser T, et al. P2X7 receptor signaling in stress and depression. Int J Mol Sci. 2019;20(11):2778. doi: 10.3390/ijms20112778.
   PubMed Web of Science ®Google Scholar
• Kouba BR, Gil-Mohapel J, S Rodrigues AL. NLRP3 inflammasome: from pathophysiology to therapeutic target in major depressive disorder. Int J Mol Sci. 2022;24(1):133.
   PubMed Web of Science ®Google Scholar
• Hendrickx DAE, van Eden CG, Schuurman KG, et al. Staining of HLA-DR, Iba1 and CD68 in human microglia reveals partially overlapping expression depending on cellular morphology and pathology. J Neuroimmunol. 2017;309:12–22. doi: 10.1016/j.jneuroim.2017.04.007.
   PubMed Web of Science ®Google Scholar
• Cosenza-Nashat MA, Kim MO, Zhao ML, et al. CD45 isoform expression in microglia and inflammatory cells in HIV-1 encephalitis. Brain Pathol. 2006;16(4):256–265. doi: 10.1111/j.1750-3639.2006.00027.x.
   PubMed Web of Science ®Google Scholar
• Sedgwick JD, Schwender S, Imrich H, et al. Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proc Natl Acad Sci U S A. 1991;88(16):7438–7442. doi: 10.1073/pnas.88.16.7438.
   PubMed Web of Science ®Google Scholar
• Antoniuk S, Bijata M, Ponimaskin E, et al. Chronic unpredictable mild stress for modeling depression in rodents: meta-analysis of model reliability. Neurosci Biobehav Rev. 2019;99:101–116. doi: 10.1016/j.neubiorev.2018.12.002.
   PubMed Web of Science ®Google Scholar
• Lin YH, Liu AH, Xu Y, et al. Effect of chronic unpredictable mild stress on brain-pancreas relative protein in rat brain and pancreas. Behav Brain Res. 2005;165(1):63–71. doi: 10.1016/j.bbr.2005.06.034.
   PubMed Web of Science ®Google Scholar
• Ögün MN, Çetinkaya A, Beyazçiçek E. The effect of vortioxetine on penicillin-induced epileptiform activity in rats. Arq Neuro-Psiquiatr. 2019;77(6):412–417. doi: 10.1590/0004-282x20190064.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang Y, Wang L, et al. Dopamine receptor D2 and associated microRNAs are involved in stress susceptibility and resistance to escitalopram treatment. Int J Neuropsychopharmacol. 2015;18(8):pyv025.
   PubMed Web of Science ®Google Scholar
• Liu MY, Yin CY, Zhu LJ, et al. Sucrose preference test for measurement of stress-induced anhedonia in mice. Nat Protoc. 2018;13(7):1686–1698. doi: 10.1038/s41596-018-0011-z.
   PubMed Web of Science ®Google Scholar
• Porsolt RD, Anton G, Blavet N, et al. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol. 1978;47(4):379–391. doi: 10.1016/0014-2999(78)90118-8.
   PubMed Web of Science ®Google Scholar
• Porsolt RD, Bertin A, Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther. 1977;229(2):327–336.
   PubMedGoogle Scholar
• Karolewicz B, Paul IA. Group housing of mice increases immobility and antidepressant sensitivity in the forced swim and tail suspension tests. Eur J Pharmacol. 2001;415(2-3):197–201. doi: 10.1016/s0014-2999(01)00830-5.
   PubMed Web of Science ®Google Scholar
• Doguc DK, Deniz F, Ilhan I, et al. Prenatal exposure to artificial food colorings alters NMDA receptor subunit concentrations in rat hippocampus. Nutr Neurosci. 2021;24(10):784–794. doi: 10.1080/1028415X.2019.1681065.
   PubMed Web of Science ®Google Scholar
• Brotto LA, Barr AM, Gorzalka BB. Sex differences in forced-swim and open-field test behaviours after chronic administration of melatonin. Eur J Pharmacol. 2000;402(1–2):87–93. doi: 10.1016/s0014-2999(00)00491-x.
   PubMed Web of Science ®Google Scholar
• Mesembe O, Bisong S, Ekong M, et al. Neurobehavioural activity in albino Wistar rats in the open field maze following long term tobacco diet ingestion. Int J Neurol. 2008;10(2):345–363.
   Google Scholar
• Bankhead P, Loughrey MB, Fernández JA, et al. QuPath: open source software for digital pathology image analysis. Sci Rep. 2017;7(1):16878. doi: 10.1038/s41598-017-17204-5.
   PubMedGoogle Scholar
• Lu Y, Ho CS, McIntyre RS, et al. Effects of vortioxetine and fluoxetine on the level of Brain Derived Neurotrophic Factors (BDNF) in the hippocampus of chronic unpredictable mild stress-induced depressive rats. Brain Res Bull. 2018;142:1–7. doi: 10.1016/j.brainresbull.2018.06.007.
   PubMed Web of Science ®Google Scholar
• Martis L-S, Højgaard K, Holmes MC, et al. Vortioxetine ameliorates anhedonic-like behaviour and promotes strategic cognitive performance in a rodent touchscreen task. Sci Rep. 2021;11(1):9113. doi: 10.1038/s41598-021-88462-7.
   PubMed Web of Science ®Google Scholar
• Carpenter LL, Gawuga CE, Tyrka AR, et al. Association between plasma IL-6 response to acute stress and early-life adversity in healthy adults. Neuropsychopharmacology. 2010;35(13):2617–2623. doi: 10.1038/npp.2010.159.
   PubMed Web of Science ®Google Scholar
• Cubała WJ, Landowski J. C-reactive protein and cortisol in drug-naive patients with short-illness-duration first episode major depressive disorder: possible role of cortisol immunomodulatory action at early stage of the disease. J Affect Disord. 2014;152-154:534–537. doi: 10.1016/j.jad.2013.10.004.
   PubMed Web of Science ®Google Scholar
• Inserra A, Mastronardi CA, Rogers G, et al. Neuroimmunomodulation in major depressive disorder: focus on caspase 1, inducible nitric oxide synthase, and interferon-gamma. Mol Neurobiol. 2019;56(6):4288–4305. doi: 10.1007/s12035-018-1359-3.
   PubMed Web of Science ®Google Scholar
• Su WJ, Zhang Y, Chen Y, et al. NLRP3 gene knockout blocks NF-kappaB and MAPK signaling pathway in CUMS-induced depression mouse model. Behav Brain Res. 2017;322(Pt A):1–8. doi: 10.1016/j.bbr.2017.01.018.
   PubMedGoogle Scholar
• Zhang Y, Liu L, Liu YZ, et al. NLRP3 inflammasome mediates chronic mild stress-induced depression in mice via neuroinflammation. Int J Neuropsychopharmacol. 2015;18(8):1–8.
   Web of Science ®Google Scholar
• Zhang Y, Liu L, Peng YL, et al. Involvement of inflammasome activation in lipopolysaccharide-induced mice depressive-like behaviors. CNS Neurosci Ther. 2014;20(2):119–124. doi: 10.1111/cns.12170.
   PubMed Web of Science ®Google Scholar
• Alcocer-Gómez E, Casas-Barquero N, Williams MR, et al. Antidepressants induce autophagy dependent-NLRP3-inflammasome inhibition in major depressive disorder. Pharmacol Res. 2017;121:114–121. doi: 10.1016/j.phrs.2017.04.028.
   PubMed Web of Science ®Google Scholar
• Kagaya A, Kugaya A, Takebayashi M, et al. Plasma concentrations of interleukin-1beta, interleukin-6, soluble interleukin-2 receptor and tumor necrosis factor alpha of depressed patients in Japan. Neuropsychobiology. 2001;43(2):59–62. doi: 10.1159/000054867.
   PubMed Web of Science ®Google Scholar
• Stratz C, Bhatia HS, Akundi RS, et al. The anti-inflammatory effects of the 5-HT(3) receptor antagonist tropisetron are mediated by the inhibition of p38 MAPK activation in primary human monocytes. Int Immunopharmacol. 2012;13(4):398–402. doi: 10.1016/j.intimp.2012.05.013.
   PubMed Web of Science ®Google Scholar
• Levine J, Barak Y, Chengappa KN, et al. Cerebrospinal cytokine levels in patients with acute depression. Neuropsychobiology. 1999;40(4):171–176. doi: 10.1159/000026615.
   PubMed Web of Science ®Google Scholar
• Rao JS, Harry GJ, Rapoport SI, et al. Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol Psychiatry. 2010;15(4):384–392. doi: 10.1038/mp.2009.47.
   PubMed Web of Science ®Google Scholar
• Tsai SJ. Effects of interleukin-1beta polymorphisms on brain function and behavior in healthy and psychiatric disease conditions. Cytokine Growth Factor Rev. 2017;37:89–97. doi: 10.1016/j.cytogfr.2017.06.001.
   PubMed Web of Science ®Google Scholar
• Maes M, Song C, Yirmiya R. Targeting IL-1 in depression. Expert Opin Ther Targets. 2012;16(11):1097–1112. doi: 10.1517/14728222.2012.718331.
   PubMed Web of Science ®Google Scholar
• Ng A, Tam WW, Zhang MW, et al. IL-1beta, IL-6, TNF- alpha and CRP in elderly patients with depression or Alzheimer’s disease: systematic review and meta-analysis. Sci Rep. 2018;8(1):12050. doi: 10.1038/s41598-018-30487-6.
   PubMed Web of Science ®Google Scholar
• Corwin EJ, Johnston N, Pugh L. Symptoms of postpartum depression associated with elevated levels of interleukin-1 beta during the first month postpartum. Biol Res Nurs. 2008;10(2):128–133. doi: 10.1177/1099800408323220.
   PubMed Web of Science ®Google Scholar
• Koo JW, Duman RS. Evidence for IL-1 receptor blockade as a therapeutic strategy for the treatment of depression. Curr Opin Investig Drugs. 2009;10(7):664–671.
   PubMedGoogle Scholar
• Sugama S, Conti B. Interleukin-18 and stress. Brain Res Rev. 2008;58(1):85–95. doi: 10.1016/j.brainresrev.2007.11.003.
   PubMedGoogle Scholar
• Al-Hakeim HK, Al-Rammahi DA, Al-Dujaili AH. IL-6, IL-18, sIL-2R, and TNFalpha proinflammatory markers in depression and schizophrenia patients who are free of overt inflammation. J Affect Disord. 2015;182:106–114. doi: 10.1016/j.jad.2015.04.044.
   PubMed Web of Science ®Google Scholar
• Munkholm K, Weikop P, Kessing LV, et al. Elevated levels of IL-6 and IL-18 in manic and hypomanic states in rapid cycling bipolar disorder patients. Brain Behav Immun. 2015;43:205–213. doi: 10.1016/j.bbi.2014.09.021.
   PubMed Web of Science ®Google Scholar
• Herman FJ, Pasinetti GM. Principles of inflammasome priming and inhibition: implications for psychiatric disorders. Brain Behav Immun. 2018;73:66–84. doi: 10.1016/j.bbi.2018.06.010.
   PubMed Web of Science ®Google Scholar
• Pan Y, Chen XY, Zhang QY, et al. Microglial NLRP3 inflammasome activation mediates IL-1beta-related inflammation in prefrontal cortex of depressive rats. Brain Behav Immun. 2014;41:90–100. doi: 10.1016/j.bbi.2014.04.007.
   PubMed Web of Science ®Google Scholar
• Mattei D, Notter T. Basic concept of microglia biology and neuroinflammation in relation to psychiatry. Curr Top Behav Neurosci. 2020;44:9–34. doi: 10.1007/7854_2018_83.
   PubMedGoogle Scholar
• Jimenez-Mateos EM, Smith J, Nicke A, et al. Regulation of P2X7 receptor expression and function in the brain. Brain Res Bull. 2019;151:153–163. doi: 10.1016/j.brainresbull.2018.12.008.
   PubMed Web of Science ®Google Scholar
• Feng WP, Zhang B, Li W, et al. Lack of association of P2RX7 gene rs2230912 polymorphism with mood disorders: a meta-analysis. PLoS One. 2014;9(2):e88575. doi: 10.1371/journal.pone.0088575.
   PubMed Web of Science ®Google Scholar
• Green EK, Grozeva D, Raybould R, et al. P2RX7: a bipolar and unipolar disorder candidate susceptibility gene? Am J Med Genet B Neuropsychiatr Genet. 2009;150B(8):1063–1069. doi: 10.1002/ajmg.b.30931.
   PubMed Web of Science ®Google Scholar
• Grigoroiu-Serbanescu M, Herms S, Muhleisen TW, et al. Variation in P2RX7 candidate gene (rs2230912) is not associated with bipolar I disorder and unipolar major depression in four european samples. Am J Med Genet B Neuropsychiatr Genet. 2009;150B(7):1017–1021. doi: 10.1002/ajmg.b.30952.
   PubMed Web of Science ®Google Scholar
• Hejjas K, Szekely A, Domotor E, et al. Association between depression and the Gln460Arg polymorphism of P2RX7 gene: a dimensional approach. Am J Med Genet B Neuropsychiatr Genet. 2009;150B(2):295–299. doi: 10.1002/ajmg.b.30799.
   PubMed Web of Science ®Google Scholar